InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Joshi Abhay, Chief Executive Officer. Director active across 1 companies, notably Revance Therapeutics, Inc.. Aggregated, 3 filings have been published. The latest transaction was filed on 15 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€37,6172,607 shares@ €14.429142.5% of flow
Common Stock
SEC:0001209191-22-019727:0·
€25,3982,151 shares@ €11.807528.7% of flow
Common Stock
SEC:0001479290-22-000023:0·
€25,3982,151 shares@ €11.8075100.0% of flow
Common Stock
SEC:0001479290-22-000023·
3 of 3 declarations
About Joshi Abhay
Abhay Joshi is the Chief Executive Officer, President, and Head of R&D at Revance Therapeutics, Inc. In this role, he oversees the operations and research and development strategy of the company. Abhay is committed to promoting innovation and enhancing the treatments offered by Revance.
